MARKER THERAPEUTICS, INC. Other Current Liabilities
MARKER THERAPEUTICS, INC. (MRKR) had Other Current Liabilities of $804.79 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-14
- 2012-06-30: Other Liabilities, Current 255.54K EUR.
EUR
| Period end | Other Liabilities, Current |
|---|---|
| 2012-06-30 | 255.54K EUR 10-Q/A · filed 2012-09-12 |
USD
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $804.79K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.00M 10-Q · filed 2026-05-15 |
| 2025-09-30 | $328.31K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $656.63K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $411.33K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.71M 10-K · filed 2026-03-18 |
| 2024-09-30 | $903.44K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $292.57K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $353.96K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.33M 10-K · filed 2025-03-31 |
| 2023-09-30 | $367.92K 10-Q · filed 2023-11-09 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-23 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-07 |
| 2017-03-31 | $492.37K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $492.37K 10-K · filed 2018-03-23 |
| 2016-09-30 | $492.37K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $492.37K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $492.37K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $492.37K 10-K · filed 2017-03-14 |
| 2015-09-30 | $492.37K 10-Q/A · filed 2016-04-14 |
| 2015-06-30 | $492.37K 10-Q/A · filed 2016-04-14 |
| 2015-03-31 | $492.37K 10-Q/A · filed 2016-04-14 |
| 2014-12-31 | $492.37K 10-Q/A · filed 2016-04-14 |
| 2014-03-31 | $492.37K 10-Q/A · filed 2014-05-21 |
| 2013-12-31 | $492.37K 10-Q/A · filed 2014-05-21 |
| 2013-09-30 | $492.37K 10-Q · filed 2013-11-19 |
| 2013-03-31 | $443.53K 10-Q/A · filed 2013-08-19 |
| 2012-12-31 | $416.00K 10-K/A · filed 2014-04-17 |
| 2012-09-30 | $365.97K 10-Q · filed 2012-11-19 |
| 2012-06-30 | $321.44K 10-Q/A · filed 2012-09-12 |
| 2012-03-31 | $303.51K 10-Q · filed 2012-05-21 |
| 2011-12-31 | $259.75K 10-K · filed 2013-05-15 |
| 2011-09-30 | $220.97K 10-Q · filed 2011-11-21 |
| 2011-06-30 | $206.86K 10-Q · filed 2011-08-22 |
| 2010-12-31 | $141.76K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |